Journal of Cellular Biochemistry · 2018 · 12 citations · 21 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerCancer Cell Proliferation InhibitionDual-luciferase AssaysMicrorna Function In CancerMicrorna In CancerMicrorna In Cell ProliferationMicrorna ModulationMicrorna Regulation In CancerWestern Blot Analysis
Acute lymphoblastic leukemia (ALL) is one of the most common and most malign childhood cancers. In this work, we investigated the expression and function of human mature microRNA-9 (miR-9) in ALL. In ALL in vitro cell lines and in situ clinical specimens, gene expression of miR-9 was tested by qRT-PCR. MiR-9 was overexpressed in CEM/C1 and Molt-3 cells to investigate its possible anti-cancer effects on ALL in vitro proliferation, cell-cycle progression, and in vivo explant growth. The possible downstream target of miR-9, neuropilin-1 (NRP1), was examined by dual-luciferase activity assay, qRT-PCR, and Western blot. NRP1was upregulated in miR-9-overexpressed CEM/C1 and Molt-3 cells to investigate the functional involvement of NRP1 in miR-9-mediated regulation on ALL in vitro proliferation and cell-cycle progression. MiR-9 was downregulated in ALL cell lines and leukemic T-cells of ALL patients. Lentivirus-mediated miR-9 overexpression inhibited ALL in vitro proliferation, cell-cycle progression, and in vivo explant growth. NRP1 was confirmed be the downstream target of miR-9, and inversely modulated by miR-9 in ALL. NRP1 upregulation reversed the anti-cancer regulations of miR-9 on ALL in vitro proliferation and cell-cycle progression. MiR-9 is downregulated in ALL. Overexpressing miR-9 may inhibit ALL development, possible through its downstream target of NRP1.
21
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma, Jennifer J. Young, Harsha Prabhala et al. · Nature Cell Biology · 2010 · 1.3K citations · Full text
Gesche Tallen, Richard Ratei, Georg Mann et al. · Journal of Clinical Oncology · 2010 · 315 citations
Medicine, Oncology, Chemotherapy +16
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Alexandros Laios, Sharon O’Toole, Richard Flavin et al. · Molecular Cancer · 2008 · 301 citations · Full text
Medicine, Cancer Biology, Oncology +17